164 related articles for article (PubMed ID: 36464756)
21. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
Lee GH; Chatterjee A; Karademir I; Engelmann R; Yousuf A; Giurcanu M; Harmath CB; Karczmar GS; Oto A
Radiology; 2022 Nov; 305(2):399-407. PubMed ID: 35880981
[TBL] [Abstract][Full Text] [Related]
22. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.
Alabousi M; Salameh JP; Gusenbauer K; Samoilov L; Jafri A; Yu H; Alabousi A
BJU Int; 2019 Aug; 124(2):209-220. PubMed ID: 30929292
[TBL] [Abstract][Full Text] [Related]
23. Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study.
Zhao L; Bao J; Qiao X; Jin P; Ji Y; Li Z; Zhang J; Su Y; Ji L; Shen J; Zhang Y; Niu L; Xie W; Hu C; Shen H; Wang X; Liu J; Tian J
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):727-741. PubMed ID: 36409317
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study.
Brembilla G; Giganti F; Sidhu H; Imbriaco M; Mallett S; Stabile A; Freeman A; Ahmed HU; Moore C; Emberton M; Punwani S
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204322
[TBL] [Abstract][Full Text] [Related]
25. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group.
Cho J; Ahn H; Hwang SI; Lee HJ; Choe G; Byun SS; Hong SK
Prostate Int; 2020 Dec; 8(4):146-151. PubMed ID: 33425791
[TBL] [Abstract][Full Text] [Related]
26. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
Junker D; Steinkohl F; Fritz V; Bektic J; Tokas T; Aigner F; Herrmann TRW; Rieger M; Nagele U
World J Urol; 2019 Apr; 37(4):691-699. PubMed ID: 30078170
[TBL] [Abstract][Full Text] [Related]
27. Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
Kang Z; Min X; Weinreb J; Li Q; Feng Z; Wang L
AJR Am J Roentgenol; 2019 Feb; 212(2):357-365. PubMed ID: 30512996
[TBL] [Abstract][Full Text] [Related]
28. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS.
Noh TI; Shim JS; Kang SG; Sung DJ; Cheon J; Sim KC; Kang SH
Sci Rep; 2022 Nov; 12(1):20689. PubMed ID: 36450813
[TBL] [Abstract][Full Text] [Related]
29. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
[TBL] [Abstract][Full Text] [Related]
30. Current Status of Biparametric MRI in Prostate Cancer Diagnosis: Literature Analysis.
Belue MJ; Yilmaz EC; Daryanani A; Turkbey B
Life (Basel); 2022 May; 12(6):. PubMed ID: 35743835
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
[TBL] [Abstract][Full Text] [Related]
32. Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.
Arcot R; Sekar S; Kotamarti S; Krischak M; Michael ZD; Foo WC; Huang J; Polascik TJ; Gupta RT
Abdom Radiol (NY); 2022 Aug; 47(8):2917-2927. PubMed ID: 35674785
[TBL] [Abstract][Full Text] [Related]
33. [Clinical impact of abbreviated unenhanced prostate protocols in magnetic resonance imaging].
Solyanik O; Heimer M
Radiologe; 2021 Sep; 61(9):810-817. PubMed ID: 34297140
[TBL] [Abstract][Full Text] [Related]
34. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of the value of dynamic contrast enhanced (DCE) imaging for prostate cancer detection, with pathology correlation.
Al Salmi I; Menezes T; El-Khodary M; Monteiro S; Haider EA; Alabousi A
Can J Urol; 2020 Jun; 27(3):10220-10227. PubMed ID: 32544044
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of integrated
Zeng Y; Leng X; Liao H; Jiang G; Chen P
Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
[TBL] [Abstract][Full Text] [Related]
37. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
[TBL] [Abstract][Full Text] [Related]
38. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
[TBL] [Abstract][Full Text] [Related]
39. A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk.
Bass EJ; Pantovic A; Connor M; Gabe R; Padhani AR; Rockall A; Sokhi H; Tam H; Winkler M; Ahmed HU
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):596-611. PubMed ID: 33219368
[TBL] [Abstract][Full Text] [Related]
40. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
